With a market cap of $44.6 billion, Kimberly-Clark Corporation (KMB) is a global leader in the manufacturing and marketing of ...

Kimberly-Clark's North American sales saw a 1.1% organic growth with slight volume increases, although supply chain disruptions somewhat affected profits. The company navigated these headwinds through ...

UBS analyst Peter Grom raised the firm’s price target on Kimberly-Clark (KMB) to $134 from $132 and keeps a Neutral rating on the shares.

Kimberly-Clark forecast annual adjusted profit growth ahead of Wall Street estimates and reported better-than-expected quarterly sales on Tuesday as the Kleenex tissue maker benefited from a ...